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We have introduced a reverse transcriptase polymerase
chain reaction based method to measure mRNA levels
of the melanogenesis enzymes tyrosinase, tyrosinase-
related-protein 1 (TRP-1), and tyrosinase-related-
protein 2 (TRP-2). Expression was determined by
reverse transcriptase-competitive multiplex polymerase
chain reaction of (i) melanogenesis enzyme transcripts
and the ‘‘housekeeping’’ gene glyceraldehyde-3-phos-
phate dehydrogenase, and (ii) two internal standards
consisting of mutated melanogenesis enzyme cDNA
and mutated gene glyceraldehyde-3-phosphate dehydro-
genase cDNA. This was investigated on in vitro cultured
melanocytes in the presence of three different steroids;
one glucocorticoid (betamethasone-17-valerate) and two
The main characteristic of skin melanocytes is theirability to synthesize the pigment melanin. At least threedifferent enzymes are involved in human eumelano-genesis. Tyrosinase (EC 1.14.18.1) is a copper bindingglycoprotein that catalyzes the hydroxylation of L-
tyrosine to L-Dopa as well as the oxidation of L-Dopa to L-
Dopaquinone. Later in that pathway, tyrosinase converts 5,6-
dihydroxyindol to indol-5,6-quinone (Ko¨rner and Pawelek, 1982;
Hearing and Jimenez, 1987). All subsequent reactions from dopaqui-
none to eumelanin can progress slowly without enzymes (Prota, 1988).
The key role of tyrosinase also becomes apparent in mutations
within the tyrosinase gene that lead to the phenotype of albinism
(Chintamaneni et al, 1991; Tomita, 1993).
Within the melanocyte, eumelanogenesis is submitted to further
control by tyrosinase-related-protein 1 (TRP-1) and tyrosinase-related-
protein 2 (TRP-2), which catalyze later steps within the pathway.
They are involved in the modulation of both quality and quantity of
eumelanin, demonstrated by mutations in TRP-1 (brown) and TRP-2
(slaty), which change the coat color of mice to brown (Zdarsky et al,
1990) and gray (Jackson et al, 1992), respectively. TRP-2 or dopachrome
tautomerase (EC 5.3.3.12) is an iron and zinc binding glycoprotein
(Solano et al, 1996) that accelerates the rearrangement from dopachrome
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sex steroids (diethylstilbestrol and estradiol). All three
steroids lead to an increase of about 1.5–2.5-fold of
tyrosinase transcripts. The amount of TRP-1 transcripts
was likewise enhanced, but only moderately (µ1.5-
fold). In contrast, TRP-2 transcripts were reduced
by µ40% in number after betamethasone-17-valerate
treatment, whereas the two sex steroids, diethylstilbestrol
and estradiol, caused an upregulation of about 20-fold
of the initial TRP-2 transcript level. We therefore
suggest that hyperpigmentation during pregnancy or
under contraceptive treatment is mediated by a direct
induction of melanogenesis via sex steroids. Key words:
gene expression/melanogenesis/pigmentation. J Invest Dermatol
110:364–367, 1998
to DHICA (Aroca et al, 1990). In the presence of TRP-2, only small
amounts of DHI are integrated into the eumelanin polymer (Urabe
et al, 1993). Although TRP-1 was the first cloned enzyme of the
tyrosinase family, its catalytic function is still obscure. TRP-1 features
DHICA oxidase activity (Kobayashi et al, 1994), but also shows some
residual tyrosinase activity (Jimenez-Cervantes et al, 1993). Accordingly,
it has been proposed that mutations in the TRP-1 gene in humans
may lead to tyrosinase-positive albinism (Zhao et al, 1992; Boissy
et al, 1996).
Melanogenesis of mammalian melanocytes can be modulated by
many biologically relevant stimuli, including interleukins (Swope et al,
1991), vitamins (Tomita et al, 1988), prostaglandins (Abdel-Malek et al,
1987), interferons (Kameyama et al, 1989), ultraviolet light (Friedmann
and Gilchrest, 1987), and melanocyte stimulating hormone (Aroca
et al, 1993). The impact of these stimuli on melanogenesis at the
transcript level is somehow difficult to trace for two main reasons.
Firstly, primary human melanocytes are slowly proliferating cells both
in vivo and in vitro and therefore RNA yield is limited. Secondly, the
basal level of melanogenesis transcripts, particularly that of TRP-2,
seems to be very low in unstimulated cells. These considerations make
northern analysis impractical and require more sensitive techniques.
In this work, we have applied reverse transcriptase-competitive
multiplex PCR to normal human melanocytes in order to determine
transcript levels of tyrosinase, TRP-1, and TRP-2 in unstimulated and
steroid hormone treated cells. The hypothesis that steroid hormones,
particularly sex steroids, may influence melanogenesis is suggested by
several clinical observations pointing out alterations in skin color during
pregnancy and contraceptive administration (Grimes, 1995).
MATERIALS AND METHODS
Melanocytes culturing Melanocytes were isolated from human fetal back
skin and cultures were initiated as described previously (Ramirez-Bosca et al,
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Figure 1. Construction of an IST for competitive RT-PCR according
to Celi et al (1993).
Figure 2. Tyrosinase transcripts by reverse transcriptase-competitive
multiplex PCR. Gel electrophoresis shows signals for three different IST
concentrations (see Table I). The x-axis represents the initial number of IST
molecules for GAPDH (3103) and for tyrosinase (3104).
1992). The medium composition was that of Bernd et al (1994): F-10 basic
medium (Gibco BRL, Eggenstein, Germany), 5% fetal calf serum (Serva,
Heidelberg, Germany), 1% penicillin/streptomycin (Biochrom KG, Berlin,
Germany), 85 nM 4-O-methyl-12-O-tetradecanoylphorbol-13-acetate (Sigma,
Deisenhofen, Germany), 0.1 mM isobutymethylxanthine (Sigma), and 2.5 nM
choleratoxin (Calbiochem-Behring, Frankfurt, Germany). Cultures were
incubated at 37°C in a 10% CO2 atmosphere. For the last 48 h steroids at a
concentration of 20 µM were present in the culture medium. Betamethsone-
17-valerate, diethylstilbestrol, and estradiol were purchased from Sigma.
Primers and IST construction Quantitation of a certain mRNA species
by regular competitive RT-PCR is somehow difficult as the starting amount
of RNA has to be identical for all assays. This crucial point was circumvented
by designing a reverse transcriptase-competitive multiplex PCR that allowed
the coamplification of the gene of interest together with glyceraldehyde-3-
phophate dehydrogenase (GAPDH) as a ‘‘housekeeping’’ gene within the same
reaction tube. Figure 1 shows the procedure of IST construction. Using these
DNA constructs in combination with wild-type cDNA in competitve PCR
gives rise to PCR products that differ in size and can therefore be distinguished
by agarose gel electrophoresis. In this reverse transcriptase-competitive multiplex
PCR, cDNA of GAPDH and mutated GAPDH-IST are coamplified in order
to have ‘‘housekeeping’’ signals that remain constant.
Oligonucleotide construction was based on the published DNA sequences:
GAPDH (EMBL, Accession: M33197), Tyrosinase (EMBL, Accession: M27160,
M60296); TRP-1 (EMBL, Accession: X51420); TRP-2 (EMBL, Accession:
D28767). GAPDH primers had the following sequences: GAPDH-A, 59-ATC
TTC CAG GAG CGA GAT CC-39; GAPDH-B, 59-ACC ACT GAC ACG
TTG GCA GT-39; GAPDH-IST, 59-ACC ACT GAC ACG TTG GCA GTA
GTA GAG GCA GGG ATG ATG T-39. Primer combination GAPDH-A/B
amplifies a 502 bp product whereas the combination GAPDH-A/IST generates
an IST of 427 bp. For tyrosinase a pseudogene is described that shares a 98%
homology with exon 4 and 5 of the human tyrosinase gene (Takeda et al,
1991). The amplification of this pseudogene derived transcript was excluded
by primers that match within exon 1 (Tyr-A) and exon 2 (Tyr-B and Tyr-
IST). The nucleotide sequences are, in detail: Tyr-A, 59-TAA TAG GAC CTG
CCA GTG CT-39; Tyr-B, 59-GCA GCT TTA TCC ATG GAA CC-39; Tyr-
IST, 59-GCA GCT TTA TCC ATG GAA CCG GCT GTT GTA CTC CTC
CAA T-39. The primer combination Tyr-A/B generates an RT-PCR product
of 753 bp. Tyr-A/IST gives rise to a product of 619 bp that is used as IST.
For TRP-1, the following primers were synthesized: TRP-1-A, 59-CTT
CAG GAT TGT GAG CTG GA-39; TRP-1-B, 59-GAA AAG CTG GTC
CCT CAT GA-39; TRP-1-IST, 59-GAA AAG CTG GTC CCT CAT GAC
TCA AAT TGT GGC GTG TTG C-39. Primer combination TRP-1-A/B
amplifies a 761 bp product, TRP-1-A/IST generates a 660 bp IST.
TRP-2 primers had the following sequence: TRP-2-A, 59-GCA CAC ATG
TAA CCT CTG TG-39; TRP-2-B, 59-TCA TAT AAG CAG GCT TGG
CC-39; TRP-2-IST, 59-TCA TAT AAG CAG GCT TGG CCG AGT CTC
TGT CAA GAG TCT C-39. Primer combination TRP-2-A/B amplifies a
711 bp product whereas the combination TRP-2-A/IST generates an IST of
581 bp. All primers were synthesized by Gibco BRL.
The PCR conditions for the generation of IST were 2 µl cDNA (correspond-
ing to 0.5 µg total RNA), 20 pmol of each primer, 0.2 mM dNTP-
mix (Eurogentec, Seraing, Belgium), reaction buffer (Pharmacia, Freiburg,
Germany), and 2 U Taq-polymerase (Pharmacia) in a total volume of 25 µl.
After a hot start 35 cycles proceeded: 45 s at 94°C, 45 s at 57°C, 45 s at 72°C.
In order to amplify IST for TRP-2, 55 cycles were carried out in the presence
of 4 U Taq-polymerase. The RT-PCR derived IST were cloned into the pTAg
vector using the LigATor cloning system (R&D Systems, Abingdon, U.K.).
Several insert containing colonies were selected to be cultured. Plasmid
extraction was carried out with a Qiagen plasmid mini kit (Hilden, Germany).
Plasmid concentration (µg) was determined photometrically and consecutively
transformed into molecule concentration.
Reverse transcriptase-competitive multiplex PCR Total cellular RNA
was isolated from cell cultures by TRIzol (Gibco BRL), and digested with
0.2 U per µl XU RNase-free DNase (Boehringer, Mannheim, Germany) for
30 min at 37°C. DNA-free RNA was extracted by phenol/chloroform prior
to RT-PCR. Up to 5 µg RNA were reverse transcribed in a 20 µl volume
with Superscript II (Gibco BRL) according to the manufacturer’s instructions,
with the exception that 1 mM/dNTP (Eurogentec) and 500 ng of random
primers (Promega, Madison, WI) were used. For PCR, mastermixes were
prepared containing all PCR relevant agents but no IST. After mixture the
mastermix was given to the prepared IST dilutions (Table I).
RT-PCR conditions for tyrosinase and TRP-1 were the same as described
for the synthesis of the IST, with the exception that 0.5 mM dNTP and 5 pmol
of GAPDH primers were present. The run was terminated after 40 PCR cycles.
In order to obtain accurate TRP-2 signals, 60 cycles with initial 4 U Taq-
polymerase had to be carried out.
Quantitation of signals Ten microliters of reverse transcriptase-competitive
multiplex PCR products were run on a 2% agarose gel and stained with
ethidium bromide. In each lane four different signals should be seen – two
from each IST and two derived from the cDNA of interest. The gray level
of each signal was determined with the software Optimas 6.0 (Optimas,
Washington, DC). The ratio between IST gray levels and their respective wild-
type signals were plotted against the relative amounts of IST. Regression lines
of the three determined points were generated. The regression lines pass the
origin in order to overcome effects of background staining.
RESULTS
Reverse transcriptase-competitive multiplex PCR Before start-
ing it was confirmed that amplification of IST respective wild-type
template offer the same amplification kinetics. Therefore, coamplifica-
tions of wild-type cDNA and IST as a function of the number of
PCR cycles were carried out; no divergencies for all three assays were
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Table I. IST molecule concentrations used in reverse transcriptase-competitive multiplex PCR
Control Betamethasone-17-valerate Diethylstil-bestrol Estradiol
Tyrosinase/GAPDH A: 5 3 105; 5 3 104 5 3 105; 5 3 104 5 3 105; 5 3 104 5 3 105; 5 3 104
B: 105; 104 105; 104 105; 104 105; 104
C: 5 3 104; 5 3 103 5 3 104; 5 3 103 5 3 104; 5 3 103 5 3 104; 5 3 103
TRP-1/GAPDH A: 5 3 107; 5 3 104 5 3 107; 5 3 104 5 3 107; 5 3 104 5 3 107; 5 3 104
B: 107; 104 107; 104 107; 104 107; 104
C: 5 3 106; 5 3 103 5 3 106; 5 3 103 5 3 106; 5 3 103 5 3 106; 5 3 103
TRP-2/GAPDH A: 1.5 3 102; 3 3 104 1.5 3 102; 3 3 104 1.5 3 103; 3 3 104 5 3 103; 3 3 104
B: 5 3 101; 104 5 3 101; 104 5 3 102; 104 1.66 3 103; 104
C: 1.66 3 101; 3.3 3 103 1.66 3 101; 3.3 3 103 1.66 3 102; 3.33 3 103 0.55 3 103; 3.33 3 103
Table II. Level of melanogenic enzymes transcripts
(% respect to control untreated cells) in normal human
melanocytes incubated for 48 h with the indicated steroids
(20 µM). The experiments were carried out with two
independent RNA extractions, derived from human fetal
melanocytes of caucasian origin leading to similar relative
transcript amounts
Control Betamethasone- Diethylstilbestrol Estradiol
17-valerate
Tyrosinase 100% 163% 250% 213%
TRP-1 100% 158% 165% 154%
TRP-2 100% 63% 2350% 2091%
detected. Figure 2 represents the data observed for tyrosinase transcripts.
In the upper left corner of each graph the original RT-PCR signals
are given. In order to derive signals from the wild-type and the
respective IST, PCR conditions were adjusted by titration of IST by
serial dilutions. For highly expressed genes, high amounts of IST also
have to be present in the PCR tube, as both compete for primers and
other factors. Therefore, low abundance transcripts require low amounts
of IST. Accordingly, the competitive PCR was optimized by using a
range of different IST concentrations that all support the coamplifica-
tion. These concentrations ranged from 107 molecules for the more
expressed enzyme, TRP-1, to 150–16 molecules for the transcripts
showing the lowest level of expression, TRP-2 (see Table I). The
whole method was also adjusted as a multiplex assay that enables
the amplification of melanogenic enzymes transcripts together with
GAPDH transcripts. The four signals per lane in Fig 2 are (from below):
GAPDH-IST, GAPDH wild-type, tyrosinase-IST, and tyrosinase wild-
type. Ratios of gray levels between IST and wild-type signals were
related to the relative IST amount and regression lines were generated.
The x axis value for an IST/wild-type ratio equal to one was determined
for the different culture conditions tested. By relating these values to
those found in untreated control cells, changes of tyrosinase at the
transcriptional level were observed. Similar approaches were carried
out for TRP-1 and TRP-2.
Steroid hormone and mRNA levels of tyrosinase, TRP-1, and
TRP-2 The steroid induced effects on the melanogenesis enzyme
transcripts levels are summarized in Table II. All three steroids induce
an increase of tyrosinase transcripts, with diethylstilbestrol showing the
highest effect. The level of TRP-1 transcripts was only moderately
augmented by the steroid without a steroid-type specific effect,
indicating that the effect could be due to a general increase in the
transcription rate that steroid hormones provoke (Ringold, 1985;
Beato, 1989). The most drastic effect was detected at the transcript
level of TRP-2. The control level seems to be very low indeed, as we
estimate that only about 1–4 copies of TRP-2 transcripts are present
per cell under regular culture conditions. This basal level is even
decreased by the glucocorticoid betamethasone-17-valerate, but in
contrast both sex steroids lead to approximately a 20-fold increase of
TRP-2 transcripts.
DISCUSSION
Previous studies dealing with transcription levels of melanogenesis
enzymes were carried out on melanoma cells. The easy maintenance
of malignant cells, accompanied by high yields of mRNA, make them
suitable for northern blot analysis. Nevertheless melanoma cell lines
show different properties to normal human skin melanocytes. At the
pigmentation level this is indicated by altered enzyme activities and
melanin contents (Bernd et al, 1994). In order to have a more
physiologic system we looked for a more sensitive approach that
allowed working with normal human melanocytes.
It has been shown that the combined use of reverse transcription
followed by PCR is a powerful tool to achieve quantitative information
on messenger RNA levels (for a review see Siebert and Larrick,
1992; Zimmermann and Mannhalter, 1996). As already mentioned by
Willey et al (1997), reverse transcriptase-competitive multiplex PCR
offers more reproducible results than northern assays. For some
quantitative RT-PCR measurements it is necessary to obtain data
during the exponential phase of the reaction. In contrast, the method
used here starts with an initial ratio of target-to-competitor cDNA
that remains constant throughout the whole amplification – even in
the plateau phase (Becker-Andre and Hahlbrock, 1989; Gilliland et al,
1990; Nedelman et al, 1992). One common concern about reverse
transcriptase-competitive multiplex PCR is that the scale of ‘‘house-
keeping’’ gene transcripts is not comparable with that of low abundance
gene transcripts. Therefore coamplification of both cDNA species in one
tube was thought to be impossible. This objection was circumvented by
(i) adjusting the plateau phase for housekeeping transcripts by low
primer concentration (5 pmol GAPDH primers), and (ii) adding
enough GAPDH-IST to compete with the wild-type cDNA for
primer molecules, deoxynucleotides, etc. in order to slow down the
amplification kinetics of the wild-type GAPDH. Our results permit
an accurate amplification of GAPDH and melanogenic enzyme tran-
scripts by reverse transcriptase-competitive multiplex PCR (Fig 2),
which makes this assay useful for quantitation of low levels of
melanogenesis enzyme transcripts.
For several years, observations of increased skin pigmentation
associated with pregnancy and estrogen administration have suggested
that melanocytes may be under sexual hormone influence. During
pregnancy the formation of melasma in the face is very common, and
a darkening of the linea alba can also occur (Beischer and Wein, 1996).
These pigmentation disorders are also found under contraceptive
medication that suggests sex steroid hormones as candidates for positive
regulative elements in melanogenesis. The fact that genitalia and breast
nipples are more heavily pigmented than surrounding skin areas well
suits this concept. The existence of specific receptors for estrogens and
other steroids in malignant melanoma cells (Fisher et al, 1976; Neifeld
and Lippmann, 1980) supported this hypothesis. Interestingly, estradiol
does not seem to affect plating efficiency or growth of melanoma cell
lines and melanocytes, respectively (Feucht et al, 1988). Although it is
clearly assumed that steroids have a stimulatory effect on melanogenesis,
the mechanism has still not been clarified. Recent experiments in B16
mouse malignant melanocytes indicate that dexamethasone caused an
increase in the tyrosinase mRNA levels (Ito et al, 1991), but no data
on TRP-1 and TRP-2 are available. In turn, the effects are not
restricted to malignant cells, because successful results with topical
corticosteroids in patients with vitiligo have been reported during the
last two decades (Kandil, 1970; Bleehen, 1976; Kumari, 1984; Liu
et al, 1990; Muto et al, 1995). Concerning normal human melanocytes,
no data about melanogenic enzymes at the transcriptional level are
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available as the bottle-neck for previous studies was the low yield of
RNA, which makes northern blot analysis impractical.
For the first time, our in vitro data show that sex steroids cause an
increase of all three melanogenesis enzyme transcripts in normal human
melanocytes. Tyrosinase, which catalyzes the rate-limiting steps in
melanogenesis, was upregulated about 2–2.5 fold. This data is in
concert with the findings of McLeod et al (1994), who found an
estradiol mediated upregulation of tyrosinase enzyme activity of about
the same range. Expression of TRP-1 was also upregulated, but to a
lower degree, as this transcript is the most abundant within the
melanocyte and is therefore insensitive to large changes. The most
drastic effects of sex steroids were observed at the TRP-2 transcript
level. This is surprising because TRP-2 activity is almost at the
detection limit in unstimulated human melanocytes (Bernd et al, 1994).
It has been suggested that the presence of artificial mitogens like 4-
O-methyl-12-O-tetradecanoylphorbol-13-acetate, cholera toxin, and
IBMX within the culture media may be responsible for the low
amount of TRP-2. Our results demonstrate that even under these
culture conditions the level of TRP-2 transcripts could be strongly
increased by sex steroids. The biologic impact of TRP-2 in human
melanogenesis is still a matter of debate. In caucasian skin, unstimulated
cutaneous melanocytes have a low level of tyrosinase, synthesizing
predominantly pheomelanin. An increase in tyrosinase activity could
provoke the switch from pheomelanogenesis to eumelanogenesis. Thus,
TRP-2 would be needed to synthesize eumelanin safely, because TRP-
2 not only catalyzes the tautomerization of L-Dopachrome to DHICA,
but is also a protecting enzyme (Salinas et al, 1994) preventing the
formation of the highly toxic DHI. In addition, this high induction of
TRP-2 transcripts might indicate that the enzyme has an additional
unknown role. In this sense, during development of the melanoblasts
in the inner ear and forebrain of murine embryos, TRP-2 is expressed
days before tyrosinase and TRP-1. Thus, TRP-2 is expressed before
any melanin synthesis occurs, something that is difficult to reconcile
with the unique function of TRP-2 as a detoxification protein during
eumelanogenesis (Steel et al, 1992).
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